Topics

FDA rejects Nabriva's antibiotic over manufacturing concerns

06:19 EDT 1 May 2019 | pharmaphorum

The FDA has rejected a proposed antibiotic from the Irish biotech Nabriva Therapeutics, citing concerns about manufacturing standards. News of the rejection comes at a time when there is a pressing need for new antibiotics because of the rise of b...

Original Article: FDA rejects Nabriva's antibiotic over manufacturing concerns

NEXT ARTICLE

More From BioPortfolio on "FDA rejects Nabriva's antibiotic over manufacturing concerns"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...